Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Blind loops prepared in the small intestines of fasted,
MgSO4
-treated rats were shown to provide a simple, consistent and inexpensive means of studying mucosal colonisation by Vibrio cholerae serogroup O1. When c. 2000 cfu were injected, the number of mucosa-associated V. cholerae in each loop increased by c. 5-6 orders of magnitude in 10-14 h, without enterotoxin-induced fluid production. Scanning electronmicroscopy and culture suggested that most surface-associated organisms were present in the adherent surface mucus. V. cholerae strains varied in terms of surface-colonising capacity. Immunisation with V. cholerae given intra-intestinally greatly reduced the rate of increase and final number of mucosa-associated vibrios within the 14-h period after challenge. The method could be used to compare the immunity induced by various immunising regimens. Immunity was sometimes accompanied by intestinal mucus-borne antibody against V. cholerae
lipopolysaccharide
but was sometimes demonstrated in the absence of such antibody or of mucus-borne antibody to heat-sensitive surface protein.
...
PMID:Antibacterial immunity to Vibrio cholerae in rats. 374 75
The outer membrane permeability to beta-lactam antibiotics was determined with intact Escherichia coli cells treated with various concentrations of NaCl. It was found that the treatment of cells with moderate concentrations of NaCl caused dramatic increase in the diffusion rate of beta-lactam across the outer membrane. This increased rate of beta-lactam diffusion was not due to the high osmolarity exerted by NaCl, since the elevated osmolarity of the assay medium by sucrose had no significant effect. This increased rate of beta-lactam diffusion was restored by addition of a low concentration of
MgSO4
or CaCl2 into the assay medium. These results were interpreted as that the treatment of intact E. coli cells with moderate concentration of monovalent cations squeezed out divalent cations, which presumably destabilized the outer membranes, causing electrostatic repulsion of negatively charged
lipopolysaccharide
molecules in site.
...
PMID:Effects of cations on the outer membrane permeability of Escherichia coli. 676 63
Magnesium sulphate
is a potential treatment for acute severe asthma. However, the mechanisms and dose-response relationships are poorly understood. The first objective of this study was to examine whether inhaled magnesium sulphate exerts bronchodilator activity measured as bronchoprotection against histamine-induced bronchoconstriction in conscious guinea-pigs alone and combined with salbutamol. Secondly, we examined whether inhaled magnesium sulphate inhibits airways inflammation and function in models of neutrophilic and eosinophilic lung inflammation induced, respectively, by inhaled
lipopolysaccharide
or the inhaled antigen, ovalbumin (OVA). Airway function was measured in conscious guinea-pigs as specific airway conductance (sG
aw
) by whole-body plethysmography. Anti-inflammatory activity was measured against lung inflammatory cell influx induced by OVA inhalation in OVA-sensitised animals or by
lipopolysaccharide
(
LPS
) exposure of non-sensitised animals. Airway function (sG
aw
) was measured over 24h after OVA exposure. Airway hyperresponsiveness to inhaled histamine and inflammatory cells in bronchoalveolar lavage fluid were recorded 24h after OVA or
LPS
challenge. Histamine-induced bronchoconstriction was inhibited by inhaled magnesium sulphate or salbutamol alone and in combination, they produced synergistic bronchoprotection.
LPS
-induced neutrophil influx was inhibited by 6 days pretreatment with magnesium sulphate. Early and late asthmatic responses in OVA sensitised and challenged animals were attenuated by magnesium sulphate. Lung inflammatory cells were increased by OVA, macrophages being significantly reduced by magnesium sulphate. Nebulised magnesium sulphate protects against histamine-induced bronchoconstriction in conscious guinea-pigs and exerts anti-inflammatory activity against pulmonary inflammation induced by allergen (OVA) or
LPS
. These properties of magnesium sulphate explain its beneficial actions in acute asthma.
...
PMID:Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway. 2828 53